[1] WANG N,ZHAO D,WANG J,et al.Architecture of African swine fever virus and implications for viral assembly[J].Science,2019,366(6465):640-644. [2] REVILLA Y,PÉREZ-NÑEZ D,RICHT J A.African swine fever virus biology and vaccine approaches[J].Advances in Virus Research,2018,100:41-74. [3] 刘海余.浅谈非洲猪瘟[J].猪业科学,2018,35(10):127. LIU H Y.Discussion on African swine fever[J].Swine Industry Science,2018,35(10):127.(in Chinese) [4] ATUHAIRE D K,AFAYOA M,OCHWO S,et al.Molecular characterization and phylogenetic study of African swine fever virus isolates from recent outbreaks in Uganda (2010-2013)[J].Virology Journal,2013,10:247. [5] DIXON L K,STAHL K,JORI F,et al.African swine fever epidemiology and control[J].Annual Review of Animal Biosciences,2020,8:221-246. [6] O'NEILL X,WHITE A,RUIZ-FONS F,et al.Modelling the transmission and persistence of African swine fever in wild boar in contrasting European scenarios[J].Scientific Reports,2020,10(1):5895. [7] 王华,王君玮,徐天刚,等.非洲猪瘟的疫情分布和传播及其控制[J].中国兽医科学,201040(4):438-440. WANG H,WANG J W,XU T G,et al.Review on spread,transmission and control of African swine fever[J]. Chinese Veterinary Science,2010,40(4):438-440.(in Chinese) [8] LIU L,WANG X,MAO R,et al.Research progress on live attenuated vaccine against African swine fever virus[J].Microbial Pathogenesis,2021,158:105024. [9] SCADENA-FERNÁNDEZ E,SÁNCHEZ-VIZCAÍNO J M,VAN DEN BORN E,et al.High doses of inactivated African swine fever virus are safe,but do not confer protection against a virulent challenge[J].Vaccines,2021,9(3):242. [10] WU K,LIU J,WANG L,et al.Current state of global African swine fever vaccine development under the prevalence and transmission of ASF in China[J].Vaccines,2020,8(3):531. [11] WANG F,ZHANG H,HOU L,et al.Advance of African swine fever virus in recent years[J].Research in Veterinary Science,2021,136:535-539. [12] LIM H X,LIM J,POH C L.Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine[J].Medical Microbiology and Immunology,2021,210(1):1-11. [13] 高瞻,邵军军,常艳燕,等.非洲猪瘟病毒p72蛋白抗原表位预测分析及多表位疫苗的构建[J].中国兽医杂志,2020,56(1):13-17. GAO Z,SHAO J J,CHANG Y Y,et al.Epitope prediction analysis of African swine fever virus p72 protein and construction of multi-epitope vaccine[J].Chinese Journal of Veterinary Medicine,2020,56(1):13-17.(in Chinese) [14] PHILLIPS M E.Epitope mapping of African swine fever virus p72 capsid protein using polyclonal.swine sera and monoclonal antibodies[D].Kansas:Kansas State University,2016. [15] 郭晶,李重阳,孟庆玲,等.非洲猪瘟病毒多表位融合蛋白P72的构建、表达及免疫学特性研究[J].家畜生态学报,2019,40(6):60-65. GUO J,LI C Y,MENG Q L,et al.Research on construction,expression and immunological characteristics of multi-epitope fusion antigen P72 of African swine fever virus[J].Journal of Domestic Animal Ecology,2019,40(6):60-65.(in Chinese) [16] GALINDO I,ALONSO C.African swine fever virus:A review[J].Viruses,2017,9(5):103. [17] 刘雪婷,王召阳,鑫婷,等.非洲猪瘟病毒B438L蛋白的原核表达及其多克隆抗体的制备与鉴定[J].中国畜牧兽医,2021,48(3):991-1000. LIU X T,WANG Z Y,XIN T,et al.Prokaryotic expression and polyclonal antibodies preparation and identification of African swine fever virus B438L protein[J].China Animal Husbandry&Veterinary Medicine,2021,13(3):991-1000.(in Chinese) [18] BORCA M V,IRUSTA P,CARRILLO C,et al.African swine fever virus structural protein p72 contains a conformational neutralizing epitope[J].Virology,1994,201(2):413-418. [19] 谢灵志.表达ASFV保护性抗原重组腺病毒载体疫苗的初步研制[D].扬州:扬州大学,2019. XIE L Z.Preliminary study of recombinant adenoviral vector vaccine expressing ASFV protective antigen[D].Yangzhou:Yangzhou University,2019.(in Chinese) [20] CHEN X,YANG J,JI Y,et al.Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice[J].Virologica Sinica,2016,31(2):150-159. [21] GERSHONI J M,ROITBURD-BERMAN A,SIMAN-TOV D D,et al.Epitope mapping[J].BioDrugs,2007,21(3):145-156. [22] 唐华.A型口蹄疫病毒AF72株合成肽疫苗的研究及其免疫效力的评估[D].北京:中国农业科学院,2013. TANG H.Study and immunity assessment of synthetic peptide vaccines against AF72 strain of Foot-and-mouth disease virus type A[D].Beijing:Chinese Academy of Agricultural Sciences,2013.(in Chinese) [23] 陈俊伊.EV-D68 VP1亚单位疫苗和多肽疫苗的免疫原性及保护性研究[D].重庆:重庆医科大学,2020. CHEN J Y.Immunogenicity and protection of EV-D68 VP1 subunit vaccine and peptide vaccine[D].Chongqing:Chongqing Medical University,2020.(in Chinese) [24] 闫宗斌,伍生军,杨静,等.猪附红细胞体eno基因重组蛋白的制备及免疫效果研究[J].中国畜牧兽医,2020,47(7):2231-2238. YAN Z B,WU S J,YANG J,et al.Preparation of recombinant protein of Mycoplasma suis eno gene and its immunity effect[J].China Animal Husbandry&Veterinary Medicine,2020,47(7):2231-2238.(in Chinese) [25] 孟媛,曾嘉庆,于成东,等.塞尼卡病毒VP1蛋白亚单位候选疫苗小鼠免疫评价[J].中国兽医学报,2021,41(11):2085-2090. MENG Y,ZENG J Q,YU C D,et al.Immune evaluation of candidate Seneca virus VP1 protein subunit vaccine in mice[J].Chinese Journal of Veterinary,2021,41(11):2085-2090.(in Chinese) [26] 魏冰.两种Th表位合成肽对O型口蹄疫病毒合成肽疫苗免疫增效作用的研究[D].天津:天津农学院,2016. WEI B.Study on synergistic effect of two Th epitopes synthetic peptides on O-type Foot-and-mouth disease virus synthetic peptide vaccine[D].Tianjin:Tianjin Agricultural University,2016.(in Chinese) |